B cell phenotype and serum levels of interferons, BAFF, and APRIL in multisystem inflammatory syndrome in children associated with COVID-19 (MIS-C)

[1]  D. Irimia,et al.  Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in children , 2022, Cell Reports Medicine.

[2]  H. Kuo,et al.  Comparable bidirectional neutrophil immune dysregulation between Kawasaki disease and severe COVID-19 , 2022, Frontiers in Immunology.

[3]  L. Notarangelo,et al.  Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C , 2022, Frontiers in Immunology.

[4]  M. Askenazi,et al.  Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19 , 2022, Nature Medicine.

[5]  B. Sitek,et al.  Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection , 2022, Proceedings of the National Academy of Sciences.

[6]  E. Wherry,et al.  Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction , 2021, Nature Communications.

[7]  P. Kearns,et al.  The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery , 2021, iScience.

[8]  G. Alter,et al.  The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children. , 2021, The Journal of clinical investigation.

[9]  Benjamin S. Glicksberg,et al.  Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children , 2021, Nature Communications.

[10]  U. Demkow,et al.  Recurrent assessment of lymphocyte subsets in 32 patients with multisystem inflammatory syndrome in children (MIS‐C) , 2021, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[11]  D. Hafler,et al.  Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children , 2021, Immunity.

[12]  M. H. Cheng,et al.  HLA class I-associated expansion of TRBV11-2 T cells in Multisystem Inflammatory Syndrome in Children. , 2021, The Journal of clinical investigation.

[13]  E. Wherry,et al.  Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19 , 2021, Science Immunology.

[14]  Steven M. Holland,et al.  Autoantibodies against type I IFNs in patients with life-threatening COVID-19 , 2020, Science.

[15]  K. Wilson,et al.  Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C) , 2020, Cell.

[16]  M. Malim,et al.  Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection , 2020, Nature Medicine.

[17]  K. Sullivan,et al.  Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. , 2020, The Journal of clinical investigation.

[18]  Yoshiya Tanaka,et al.  B cell phenotypes, signaling and their roles in secretion of antibodies in systemic lupus erythematosus. , 2017, Clinical immunology.

[19]  J. Muñóz-Valle,et al.  Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus , 2016, Lupus.

[20]  J. Harley,et al.  Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification , 2016, Annals of the rheumatic diseases.

[21]  K. Tung,et al.  Neutrophils Contribute to Excess Serum BAFF Levels and Promote CD4+ T Cell and B Cell Responses in Lupus-Prone Mice , 2014, PloS one.

[22]  P. Schneider,et al.  The BAFF/APRIL system in SLE pathogenesis , 2014, Nature Reviews Rheumatology.

[23]  Y. Crow.  Type I interferonopathies: a novel set of inborn errors of immunity , 2011, Annals of the New York Academy of Sciences.

[24]  N. Kamatani,et al.  Excessive Production of IFN-γ in Patients with Systemic Lupus Erythematosus and Its Contribution to Induction of B Lymphocyte Stimulator/B Cell-Activating Factor/TNF Ligand Superfamily-13B1 , 2008, The Journal of Immunology.

[25]  T. McGaha,et al.  APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. , 2008, Blood.

[26]  J. Pers,et al.  BAFF Overexpression Is Associated with Autoantibody Production in Autoimmune Diseases , 2005, Annals of the New York Academy of Sciences.

[27]  M. Scott,et al.  An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent Pathway , 2001, Science.

[28]  D. Kono,et al.  The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity , 2001, Arthritis research.

[29]  G. Sturfelt,et al.  Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies , 2000, Lupus.